Skip to content
Homepage
Author:
UBRIGENE BIOSCIENCES INC
Posted Date:
May 4, 2026
uBriGene and Cellinfinity BIO Announce Strategic Partnership to Advance In Vivo CAR-T Therapies
UBRIGENE BIOSCIENCES INC
May 4, 2026
uBriGene Congratulates Strategic Partner Grit Biotechnologies on FDA IND Clearance for Its Next-Generation GT307 TIL Therapy
UBRIGENE BIOSCIENCES INC
May 2, 2026
